跳至主要内容
临床试验/JPRN-jRCTs032190061
JPRN-jRCTs032190061已完成3 期

The validation study of detectability and diagnostic accuracy of AI-aided endoscopic diagnosis system for colonoscopy; multicentric study - CAD-COLON study

Tamai Naoto0 个研究点目标入组 358 人开始时间: 2019年7月24日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
358

研究概览

简要总结

A total of 358 patients were enrolled and 179 patients were assigned to the SC-first group or CADe-first group. The AMR of the CADe-first group was significantly lower than that of the SC-first group (13.8%vs.36.7%,P<0.0001). Similar results were observed for the polyp miss rate (14.2%vs.40.6%,P<0.0001). The adenoma detection rate of CADe-assisted colonoscopy was 64.5%, which was significantly higher than that of standard colonoscopy (53.6%;P=0.036).

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 40age old 至 < 80age old(—)
性别
All

入选标准

  • In patients scheduled for colonoscopy / treatment, patients who meet the following criteria.
  • 1.40-80 years old
  • 2.Patients who gave written informed consent based on their own intention after receiving sufficient explanation about this study
  • 3.Informed consensus has been obtained that endoscopic resection should be performed if a lesion is found
  • 4.The examination purpose is for screening of colon cancer or surveillance after endoscopic treatment of colorectal lesions

排除标准

  • 1.Patients with known inflammatory bowel disease and colonic stenosis
  • 2.Patients with known familial adenomatous polyposis syndrome
  • 3.Patients with known colorectal cancer/polyp
  • 4.Patients who have had colon surgery in the past (except for appendectomy and surgery on the anus)
  • 5.Patients with high risk of bleeding after endoscopic treatment, and difficult management of anticoagulation or antiplatelet agent.
  • 6.Patients with severe organ failure (cirrhosis of Child C, heart failure of ACC / AHA stage D)
  • 7.Pregnant patient
  • 8.Patients who are judged as ineligible for registration by attending doctors

研究者

发起方
Tamai Naoto

相似试验